Description
Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases. LENVIMA (lenvatinib) is a prescription medicine that is used to treat certain kinds of cancer.
| Strength | 4 mg |
| Pack Size | Not specified |
| Brand | Lenvima |
| Packaging Type | Not specified |
| Composition | Not specified |
| Form | Capsules |
| Shelf Life | Not specified |
| Usages | Not specified |
| Country of Origin | Not specified |
